Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A boost for biomanufacturing
December 2016
SHARING OPTIONS:

CAMBRIDGE, U.K.—In its efforts to support biologic therapeutic manufacturing at home and abroad, Horizon Discovery Group plc has inked new partnerships with the Centre for Process Innovation (CPI) and the National Institute for Bioprocessing Research and Training (NIBRT). Under the license agreement, any organization can access Horizon’s biomanufacturing cell lines, through CPI or NIBRT, for research purposes. Horizon is developing cell lines for manufacturing a variety of current and next-generation biological therapeutics and hopes to boost innovation in other companies by offering access to its bioproduction cell line platform, called CHO SOURCE.
 
“Horizon is committed to driving innovation in bioprocessing,” Darrin Disley, CEO of Horizon Discovery, said in a press release. “We value the opportunity to work with key industry players, including CPI and NIBRT, to ensure that we are delivering the best solutions for our customers and ultimately for patients.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.